Detalhe da pesquisa
1.
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
Eur Respir J
; 62(5)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827576
2.
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
Emerg Infect Dis
; 26(11): 2709-2712, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917293
3.
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
Eur Respir J
; 49(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529205
4.
Association of IFN-γ +874 A/T SNP and hypermethylation of the -53 CpG site with tuberculosis susceptibility.
Front Cell Infect Microbiol
; 13: 1080100, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36743307
5.
PGE2 displays immunosuppressive effects during human active tuberculosis.
Sci Rep
; 11(1): 13559, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193890
6.
The Non-synonymous rs763780 Single-Nucleotide Polymorphism in IL17F Gene Is Associated With Susceptibility to Tuberculosis and Advanced Disease Severity in Argentina.
Front Immunol
; 10: 2248, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616423
7.
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.
J Infect
; 78(1): 35-39, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096332
8.
IL17A augments autophagy in Mycobacterium tuberculosis-infected monocytes from patients with active tuberculosis in association with the severity of the disease.
Autophagy
; 13(7): 1191-1204, 2017 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28581888
9.
Author Correction: PGE2 displays immunosuppressive effects during human active tuberculosis.
Sci Rep
; 11(1): 18138, 2021 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493800